PET Imaging Quantifying
Colorectal Neoplasms
/ diagnostic imaging
Dipeptides
/ therapeutic use
Edetic Acid
/ analogs & derivatives
Gallium Isotopes
Gallium Radioisotopes
Heterocyclic Compounds, 1-Ring
/ therapeutic use
Humans
Lutetium
Neoplasm Metastasis
Oligopeptides
/ pharmacokinetics
Positron-Emission Tomography
/ methods
Prostate-Specific Antigen
Radioisotopes
Radiopharmaceuticals
/ pharmacokinetics
PET
metastatic colorectal cancer
peptide receptor radionuclide therapy
theranostics
Journal
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410
Informations de publication
Date de publication:
11 2020
11 2020
Historique:
received:
20
07
2019
accepted:
09
03
2020
pubmed:
3
5
2020
medline:
10
3
2021
entrez:
3
5
2020
Statut:
ppublish
Résumé
At diagnosis, 22% of colorectal cancer (CRC) patients have metastases, and 50% later develop metastasis. Peptide receptor radionuclide therapy (PRRT), such as
Identifiants
pubmed: 32358088
pii: jnumed.119.233312
doi: 10.2967/jnumed.119.233312
doi:
Substances chimiques
Dipeptides
0
Gallium Isotopes
0
Gallium Radioisotopes
0
Heterocyclic Compounds, 1-Ring
0
Oligopeptides
0
PSMA-617
0
Radioisotopes
0
Radiopharmaceuticals
0
gallium 68 PSMA-11
0
Lutetium
5H0DOZ21UJ
Edetic Acid
9G34HU7RV0
Lutetium-177
BRH40Y9V1Q
Prostate-Specific Antigen
EC 3.4.21.77
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1576-1579Informations de copyright
© 2020 by the Society of Nuclear Medicine and Molecular Imaging.